Clzumab 100 mg Injection
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Clzumab 100 mg Injection

Clzumab 100 mg Injection

Clzumab 100 mg Injection contains bevacizumab 100 mg and is a targeted anticancer medicine used in the treatment of certain cancers. It is used as part of specific treatment regimens for colorectal, lung, kidney, and other cancers. The injection is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Bevacizumab is a monoclonal antibody that blocks vascular endothelial growth factor (VEGF), helping reduce the formation of new blood vessels that support tumor growth. It may be combined with chemotherapy or other anticancer medicines according to the cancer type and prescribed treatment protocol. Patients may require monitoring for blood pressure changes, bleeding, protein in the urine, wound-healing complications, and other treatment-related effects. The dose and infusion schedule are determined by the treating oncologist according to the indication and individual patient factors.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Dosage Form Injection
Volume 4 mL
Route of Administration Intravenous infusion
Manufacturer Hetero Healthcare Ltd.

Product Also Known As

Clzumab 100mg Injection, Clzumab 100 mg Injection, Clzumab 100 Injection, Bevacizumab 100mg Injection, Bevacizumab 100 mg Injection, Bevacizumab Injection 100mg, Bevacizumab 100mg Vial